Clinical trials sponsored by Supernus Pharmaceuticals, Inc.

Phase breakdown

Conditions studied

Recruiting trials led by Supernus Pharmaceuticals, Inc.

• Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
  NCT07226661 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
  NCT04781140 · Phase: Phase 4 · Ages: 48 Months to 69 Months · Sex: All (male and female) · 47 locations
• RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
  NCT06798896 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
  NCT07219927 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
  NCT07141329 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy
  NCT05518578 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 10 locations

Common questions

How many trials is Supernus Pharmaceuticals, Inc. recruiting for?

Supernus Pharmaceuticals, Inc. is the lead sponsor of 6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.